Skip to main content
Elaine (Kozlowski) Hylek, MD, Internal Medicine, Boston, MA, Boston Medical Center

ElaineM.(Kozlowski)HylekMDMPH

Internal Medicine Boston, MA

Professor of Medicine, Boston University

Dr. Hylek is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hylek's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1988 - 1991
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 1988

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1993 - 2026

Awards, Honors, & Recognition

  • Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
  • Boston Magazine Castle Connolly, 2011-2013

Publications & Presentations

PubMed

Journal Articles

  • Treatment Persistence in Atrial Fibrillation: The Next Major Hurdle  
    Elaine (Kozlowski) Hylek, MD, Thrombosis and Haemostasis
  • Original Investigation Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients with Atrial Fibrillation: An ARISTOTLE Substudy  
    John H Alexander, Elaine M Hylek, ScienceDirect
  • Choosing a Particular Oral Anticoagulant and Dose for Stroke Prevention in Individual Patients with Non-Valvular Atrial Fibrillation: Part 1  
    Jonathan L Halperin, Elaine M Hylek, Michael D Ezekowitz, James Aisenberg, European Heart Journal

Lectures

  • Unanswered Questions on NOAC in AF Where Do We Go From Here? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019

Authored Content

  • Idarucizumab for Dabigatran Reversal — Full Cohort AnalysisJuly 2017

Press Mentions

  • Catheter-Directed Fibrinolysis Safe in Intermediate-High-Risk Pulmonary Embolism
    Catheter-Directed Fibrinolysis Safe in Intermediate-High-Risk Pulmonary EmbolismDecember 16th, 2022
  • Hints of Benefit with Catheter-Directed Thrombolysis in Intermediate/High-Risk PE
    Hints of Benefit with Catheter-Directed Thrombolysis in Intermediate/High-Risk PEOctober 19th, 2022
  • Catheter-Directed Thrombolysis Promising for Intermediate-Risk Pulmonary Embolism
    Catheter-Directed Thrombolysis Promising for Intermediate-Risk Pulmonary EmbolismOctober 19th, 2022
  • Join now to see all

Hospital Affiliations